The authors in this voices piece contributed to genetic research on non-invasive prenatal testing (NIPT) on an Asian cohort, as both pregnant women and non-European populations are under-represented in genomics datasets.
A study of maternal genetics, milk composition and the infant faecal microbiome. The results show how an improved understanding of the genetics and genomics of human milk connects lactation biology with maternal and infant health.
Pre-conception vaccination, particularly with mRNA vaccines, is associated with significant reductions in adverse pregnancy outcomes.
Analysis of the research used as a basis for clinical guideline development underscores the insufficient consideration of sex and gender in the primary evidence base informing the 2019 ESC guideline recommendations for chronic coronary syndromes. The underrepresentation of women in cardiovascular research and guideline development poses challenges for accurately discerning possible sex- and gender-specific effects and tailoring recommendations to diverse patient needs. Addressing these gaps requires explicitly integrating sex and gender considerations into study designs and guideline creation processes and promoting inclusivity to optimize clinical care provision and improve outcomes for all individuals affected by ischemic heart diseases.
The chief implication of this study for public policy is to support recommendations towards high-priority vaccination against COVID-19 in pregnant women to avoid high risks of adverse pregnancy outcomes from COVID-19 especially in the 3rd trimester.
The main public health implication of all the available evidence is that COVID-19 vaccination is to be recommended to all women of reproductive age, especially those intending to become pregnant within a year.
The number of women referred to a clinic with pregnancy-associated cancer will increase as NIPT providers will be able to better recognize malignant-suspicious NIPT from foetal aneuploidy screening. Reporting malignancy suspicious-NIPT results may be a step forward in detecting cancers and could enable an earlier diagnosis and start of cancer therapy, especially for haematological malignancies and advanced solid tumours.
Women are significantly underrepresented in the field of hematology-oncology. Pivotal trials in the immune effector cell therapy show only 29.5% female authorship. This article examines the data and suggests strategies to decrease gendered authorship disparities.
Manoj Sharma, Ram Lakhan, Chapter 8 - Women’s health, Effective Approaches to Global Health Issues, Academic Press, 2025, Pages 171-190, ISBN: 9780443290985
This content aligns with Goal 3: Good Health and Goal 5: Gender Equity through its focus on women's health, an area of special concern and importance globally.
On Wednesday 25th September 2024, the five 2024 WE Empower awardees will take part in the WE Empower SDG Challenge Pitch Night. Hosted by fashion designer, author and philanthropist, Diane Von Fur
